Month: December 2024

The Twelve Days of (OSP) Christmas

Posted on

The Twelve Days of (OSP) Christmas
Lyrics by: An old friend of OSP

On the first day of Christmas in science policy,
We started our engagement strategy!

On the second day of Christmas in science policy,
Terminology in clinical research,
And we started our engagement strategy.

On the third day of Christmas in science policy,
An AI policy resource, terminology in clinical research,
And we started our engagement strategy.

On the fourth day of Christmas in science policy,
Scientific integrity, an AI policy resource, terminology in clinical research,
And we started our engagement strategy.

On the fifth day of Christmas in science policy,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
Now we’ve named our engagement strategy.

On the sixth day of Christmas in science policy,
We honored Tuskeegee survivors,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
On the road with our engagement strategy!

On the seventh day of Christmas in science policy,
Rolled out the new DURC policy,
Honored Tuskeegee survivors,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
And implementing the engagement strategy.

On the eighth day of Christmas in science policy,
New language in informed consent.
Rolled out new DURC policy, honored Tuskeegee survivors,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
And even more engagement strategy!

On the ninth day of Christmas in science policy,
Hired awesome summer interns, informed consent language,
Rolled out new DURC policy, honored Tuskeegee survivors,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
Talked to more folks about engagement strategy!

On the tenth day of Christmas in science policy,
Went to Geneva for the BWTC,
Awesome summer interns, informed consent language,
Rolled out new DURC policy, honored Tuskeegee survivors,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
Still excited about engagement strategy!

On the eleventh day of Christmas in science policy,
Public access policy!
Geneva is expensive, awesome summer interns, informed consent language,
Rolled out new DURC policy, honored Tuskeegee survivors,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
Have I mentioned our engagement strategy?

On the twelfth day of Christmas in science policy,
Jessica Tucker is named Deputy!
Public access policy, diplomacy in Geneva, awesome summer interns, informed consent language,
Rolled out new DURC policy, honored Tuskeegee survivors,
ENGAGE is the best acronym!!
Scientific integrity, an AI policy resource, terminology in clinical research,
And continued our engagement strategy!

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric
Blog Roll

NIH Releases New Public Access Policy and Supplemental Guidance; Releases Plan for Metadata and Personal Identifiers (PIDs)

Posted on

Today, NIH is releasing its new 2024 Public Access Policy along with supplemental guidance on government license use and rights and publication costs. The final Public Access Policy builds upon NIH’s long history of providing public access to scholarly publications, and it details steps to accelerate access, particularly through removal of the current twelve-month embargo period before manuscripts are made freely available to the public.   

The policy was developed after significant public engagement and feedback and is in keeping with the 2022 Memo Ensuring Free, Immediate, and Equitable Access to Federally Funded Research.  The 2024 Public Access Policy is effective for manuscripts accepted for publication on or after December 31, 2025. Until then, NIH’s current Public Access Policy remains in effect.

In addition to the release of the 2024 Public Access Policy, NIH is also releasing its Plan on Metadata and Personal Identifiers (PIDs) for public comment. The plan outlines how researchers and institutions should be using metadata and PIDs, and also outlines proposed requirements for NIH-supported repositories to collect and make relevant metadata publicly available and searchable. 

To view the Plan and provide comments please utilize the portal found here.  Comments will be accepted until February 21, 2025. 

For additional context on these releases, please see a statement made today by NIH Director, Dr. Monica Bertagnolli, and an Under the Poliscope blog co-authored by Dr. Lyric Jorgenson and Dr. Stephen Sherry. 

If you are not yet a subscriber to this listserv, please sign up here.  Also, please consider following us on X @NIH_OSP  and LinkedIn.  

Introducing the New NIH Public Access Policy!

Posted on

Dr. Lyric Jorgenson has co-authored this blog with Dr. Stephen Sherry (r). Dr. Sherry is the Acting Director of the National Library of Medicine within NIH.

We say it all the time – NIH is the steward of the Nation’s investment in biomedical research. But what does that really mean? For us, it means making sure NIH delivers on its mission to turn discovery into health. To turn this into reality, NIH develops policies to support responsible and innovative research, and to ensure that individuals across the country can realize the benefits from their investments in research.

Need proof? NIH has long championed access to research products, whether it be access to research data (e.g., NIH Data Management and Sharing Policy), research results (e.g., 2008 NIH Public Access Policy), or even in research inventions (e.g., draft NIH IRP Access Policy). These policies reflect NIH’s unwavering commitment to helping patients, families, and healthcare providers better understand and address the most critical health concerns facing their communities and spur future research and translation of research results to new products and practices.

In that spirit, today I’m pleased to share the news that NIH is releasing a new NIH Public Access Policy to make the results of NIH-funded research accessible as quickly as possible. The new Policy, which will replace the 2008 Public Access Policy upon effective date, removes the twelve-month embargo period to provide accelerated access to published manuscripts. Importantly, NIH was cognizant while developing this Policy that it would not exacerbate potential inequities in publishing, and as such, work within the existing policy framework to minimize new burdens on the research community.

Alongside the new Policy, NIH is also releasing its plan to make it easier for researchers, clinicians, students, and the public to find and make use of research results. Particularly, NIH is outlining how researchers and institutions should leverage use of metadata and persistent identifiers and proposes new requirements for NIH-supported repositories to collect and make this information available and searchable.

More information on this plan and information on how to provide comments can be found here. These efforts are also aligned with activities across the rest of government as we all work to implement the White House Office of Science and Technology Policy’s (OSTP) memo Ensuring Free, Immediate, and Equitable Access to Federally Funded Research.

Today is a milestone day for us all, as NIH funded research will now be publicly available without delay. We look forward to hearing from you on how to continue to promote the highest level of transparency and accountability in research as we continue on this journey together.

We wish you the happiest of holidays and look forward to discussing the issue of public access more with you in 2025!

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric
Blog Roll

Dr. Jessica Tucker Appointed Deputy Director of the NIH Office of Science Policy

Posted on

After a nationwide search, Dr. Jessica Tucker has been appointed as the Deputy Director of the NIH Office of Science Policy (OSP), a position she has occupied in an acting capacity since April 2021.

Dr. Tucker is a renowned science policy expert, and has previously served in various leadership roles across the Department of Health and Human Services (HHS). Prior to her acting leadership role, she held roles as the Director of OSP’s Division of Biosafety, Biosecurity, and Emerging Biotechnology Policy and Program Director at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH where she managed a program on gene and drug delivery systems and on synthetic biology. Before her time at NIH, she worked at the HHS Office of the Assistant Secretary for Preparedness and Response and was a Visiting Assistant Professor at Stony Brook University within the Department of Technology and Society, where she conducted engineering education research and lectured within the Department of Chemical and Molecular Engineering.

Questions on this announcement can be sent to [email protected].

If you are not yet a subscriber to this listserv, please sign up here. You can follow us on X: @NIH_OSP  as well as LinkedIn.